parkinson glutathione oxidative ipsc crispr CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease Frontiers | Mitochondrial Dysfunction in
Frontiers Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy Induced Pluripotent Stem Cells Derived Cellular Models for Investigating Parkinson's Disease Pathogenesis and Drug Screening Stem Cell Reviews and Reports Springer Nature Link In vivo and in vitro perspectives in Parkinson's disease: Mechanisms and the role of phytomedicine PMC Glutathione S transferase: A keystone in Parkinson's disease pathogenesis and therapy ScienceDirect Genome editing in Parkinson's disease: Unlocking therapeutic avenues through CRISPR Cas systems ScienceDirect
Pay in 4 interest-free payments of $6.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15




